Improving pain treatment for veterans by matching them to the right therapies
Optimizing Response to Chronic Pain Treatments in Veterans: Identifying Key Moderators
This study is looking at how to help veterans with chronic pain by finding the best therapy for each person, like cognitive-behavioral therapy or mindfulness, so they can manage their pain more effectively.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11096304 on NIH RePORTER |
What this research studies
This research focuses on veterans suffering from chronic pain, aiming to enhance treatment effectiveness through personalized approaches. It investigates how individual patient characteristics can influence the success of various complementary and integrative health treatments, particularly cognitive-behavioral therapy (CBT), Mindfulness-Based Cognitive Therapy (MBCT), and Hypnotic Cognitive Therapy (HYP-CT). By identifying key factors that determine treatment response, the study seeks to develop algorithms that match patients with the therapies most likely to benefit them. This personalized matching could lead to better pain management outcomes for veterans.
Who could benefit from this research
Good fit: Ideal candidates for this research are veterans experiencing chronic pain who may benefit from cognitive-behavioral therapies.
Not a fit: Patients who do not have chronic pain or those who are not veterans may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective pain management strategies tailored to individual veterans, improving their quality of life.
How similar studies have performed: Previous research has shown promise in using personalized approaches to treatment matching, indicating potential success for this study's methodology.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Jensen, Mark P — University of Washington
- Study coordinator: Jensen, Mark P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.